Huiting Xu, Qiang Fu, Yi Zhou, Chengbin Xue, Patrick Olson, Ke K Zhang and Linglin Xie
DECREASED LEVEL OF MELATONIN IN TYPE-2 DIABETIC PATIENTS AND INFLUENCE OF ADIPOSITY AND SMOKING
Peteris Tretjakovs, Ilze Konrade, Ieva Kalera, Normunds Limba and Gita Krievina
Hanan Alhajri
Soomin Jeunga and Soon Bae Kim
GROUP CLINICS DELIVER HIGH QUALITY CARE IN CHRONIC CONDITIONS INCLUDING DIABETES
Fraser Birrell
HYDROGEN SULFIDE AS INDICATOR OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Dara Kutsyk and Elena Sklyarova
LEPTIN AND HYPERTENSION IN NONOBESE PATIENTS IN RENAL REPLACEMENT THERAPY
Vaia D Raikou and Despina Kyriaki
PROBATION: MAPPING NANOVESICLESVEHICLED PROTEINS RELEASED FROM BROWN ADIPOSE TISSUE
Daniele Lettieri Barbato
SGLT-2 INHIBITION: POTENTIAL DANGERS FOR RENAL FUNCTION AND INTEGRITY
Zaid Abassi, Zaher Armaly, Mogher Khamaisi and Samuel N Heyman
THE ANTIDIABETIC EFFECT OF LUPINE TURMOS COMPARED WITH ANTIDIABETIC DRUG (GLIBENCLAMIDE)
Laila E Taha
Dimitris T Papadimitriou
Young Jin Tak
Tricia Chang
UNTARGETED METABOLOMICS ANALYSIS IN DIFFERENT DIABETIC COMPLICATIONS
Tao Wu, Guang Ji, Mingmei Shao, Ming Yang and Haiyan Song
Shideh Montasser Kouhsari and Negar Saliani